PROCEPT BioRobotics Corporation
PRCT
ISIN US74276L1052 / Valor 113304787
PROCEPT BioRobotics Corporation
UMushroom community rating:
About company
PROCEPT BioRobotics Corporation is a pioneering medical technology company that specializes in the development and commercialization of robotic surgical systems. The company's flagship product, the AquaBeam Robotic System, represents a significant advancement in the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). This innovative system is distinguished by its use of Aquablation therapy, a unique, image-guided, and heat-free approach that offers a minimally invasive alternative to traditional surgical procedures. By leveraging robotic precision and real-time imaging, the AquaBeam Robotic System aims to improve patient outcomes, reduce recovery times, and provide a safer, more effective treatment option for millions of men worldwide suffering from BPH.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
4258 M
Market cap (USD)
233,717
Daily traded volume (Shares)
82.58 / 79.57
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
